Calcified Tissue International

, Volume 56, Supplement 1, pp S27–S28 | Cite as

Cytokines and Osteoclast Activity

  • R. Pacifici
Osteoclastic Models


Bone Resorption Osteoclast Precursor Bone Marrow Culture Cytokine Inhibitor Ovari 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    SudaT, Takahashi N, Martin TJ (1992) Modulation of osteoclast differentiation. Endocrinol Rev 13:66–80Google Scholar
  2. 2.
    Tanaka S, Takahashi N, Udagawa N, Tamura T, Akatsu T, Stanley ER, Kurokawa T, Suda T (1993) Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 91:257–263CrossRefPubMedCentralPubMedGoogle Scholar
  3. 3.
    Kimble RB, Vannice JL, Bloedow DC, Thompson RC, Hopfer W, Kung V, Brownfield C, Pacifici R (1994) Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest (in press)Google Scholar
  4. 4.
    Hustmeyer FG, Walker E, Yu XP, Girasole G, Sakagami Y, Peacock M, Manolagas SC (1993) Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis. J Bone Miner Res 8:51–59CrossRefGoogle Scholar
  5. 5.
    Pacifici R, Vannice JL, Rifas L, Kimble RB (1993) Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effect of menopause and estrogen/progesterone therapy. J Clin Endocrinol Metab 77:1135–1141PubMedGoogle Scholar
  6. 6.
    Raisz LG (1988) Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 318:818–828CrossRefPubMedGoogle Scholar
  7. 7.
    Kimble RB, Matayoshi AB, Vannice JL, Kung V, Pacifici R (1994) Simultaneous inhibition of TNF and IL-1 is required to block bone loss in the early postovariectomy period. J Bone Miner Res 8(Suppl 1):abstr 153Google Scholar
  8. 8.
    Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC (1992) Increased osteoclast development after estrogen loss: mediation by Interleukin-6. Science 257:88–91CrossRefPubMedGoogle Scholar
  9. 9.
    Kitazawa R, Kimble R, Brownfield C, Ross, P, Vannice JL, Kung V, Kenney J, Pacifici R (1994) Interleukin 1 receptor antagonist but not anti-IL-6 antibody blocks ovariectomy-induced osteoclast formation and bone resorption in mice. J Bone Miner Res 8:199AGoogle Scholar
  10. 10.
    May LT, Neta R, Moldawer LL, Kenney JS, Patel K, Sehgal PB (1993) Antibodies chaperone Circulating IL-6. J Immunol 151:3225–3236PubMedGoogle Scholar
  11. 11.
    Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F (1994) Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189–1196PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1995

Authors and Affiliations

  • R. Pacifici
    • 1
  1. 1.Division of Bone and Mineral DiseaseWashington University School of MedicineSt. LouisUSA

Personalised recommendations